NCT06798948View on ClinicalTrials.gov

Effect of the Combined Application of Cynara Scolymus, Silybum Marianum, Curcuma Longa, and Glycyrrhiza Glabra in Improving Metabolic Associated Fatty Liver Disease : a Randomized Clinical Trial

PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Metabolic-associated Fatty Liver Disease (MAFLD)
Interventions
DIETARY_SUPPLEMENT

Combination of cynara scolymus, silybum marianum, curcuma longa, and glycyrrhiza glabra

Oral combination of cynara scolymus, silybum marianum, curcuma longa, and glycyrrhiza glabra

OTHER

Placebo maltodextrin

The patient takes two tablets of the placebo maltodextrin every day

Trial Locations (2)

310005

RECRUITING

Zhejiang Xinhua Hospital, Hangzhou

310053

RECRUITING

The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou

All Listed Sponsors
collaborator

Xin Hua Hospital of Zhejiang Province

OTHER

lead

Li Lab,MD

OTHER_GOV